REG - Evraz Plc - Director/PDMR Dealing
RNS Number : 5270UEvraz Plc29 March 2019Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
EVRAZ plc was notified on 29 March 2019 by Mr. Alexander Abramov, a director of EVRAZ plc, that he placed an order to purchase EVRAZ 5.25% notes due in 2024 for total principal amount of $50m. As a result of this transaction, Mr. Alexander Abramov's holding will increase to $50m EVRAZ 5.25% notes due in 2024. Settlement of the transaction is expected to be completed on 2 April 2019.
The notification below, made in accordance with the requirements of the Article 19 of EU Market Abuse Regulation, provides further detail.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Alexander Abramov
2
Reason for the notification
a)
Position/status
Director, Non-Executive Chairman of the Board
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
EVRAZ plc
b)
LEI
5493005B7DAN39RXLK23
4
Details of the transaction(s):
a)
Description of the financial instrument, type of instrument
Identification code
5.25% notes due in 2024
XS1843443273
b)
Nature of the transaction
Purchase of notes
c)
Price(s) and volume(s)
Date/time
Price(s)
Volume(s)
Amount(s) $
(a)
2019-03-28
Par (100%)
50,000,000.00
(b)
(c)
Total
50,000,000.00
d)
Aggregated information
- Aggregated volume
- Price
e)
Date/time of the transactions
f)
Place of the transaction
Primary offering
EVRAZ plc was notified on 29 March 2019 by Mr. Alexander Frolov, a director of EVRAZ plc, that he placed an order to purchase EVRAZ 5.25% notes due in 2024 for total principal amount of $20m. As a result of this transaction, Mr. Alexander Frolov's holding will increase to $20m EVRAZ 5.25% notes due in 2024. Settlement of the transaction is expected to be completed on 2 April 2019.
The notification below, made in accordance with the requirements of the Article 19 of EU Market Abuse Regulation, provides further detail.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Alexander Frolov
2
Reason for the notification
a)
Position/status
Director, CEO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
EVRAZ plc
b)
LEI
5493005B7DAN39RXLK23
4
Details of the transaction(s):
a)
Description of the financial instrument, type of instrument
Identification code
5.25% notes due in 2024
XS1843443273
b)
Nature of the transaction
Purchase of notes
c)
Price(s) and volume(s)
Date/time
Price(s)
Volume(s)
Amount(s) $
(a)
2019-03-28
Par (100%)
20,000,000.00
(b)
(c)
Total
20,000,000.00
d)
Aggregated information
- Aggregated volume
- Price
e)
Date/time of the transactions
f)
Place of the transaction
Primary offering
EVRAZ Investor Relations
+7 495 232 1370
29 March 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHJLMJTMBTTBBL
Recent news on Evraz
See all newsREG-EVRAZ plc DISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
AnnouncementREG-EVRAZ plc CLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022
AnnouncementREG-EVRAZ plc EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
AnnouncementREG-EVRAZ plc EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
AnnouncementREG-EVRAZ plc EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
Announcement